↓ Skip to main content

Dove Medical Press

Article Metrics

Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, March 2011
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
46 Mendeley
Title
Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder
Published in
ClinicoEconomics and Outcomes Research: CEOR, March 2011
DOI 10.2147/ceor.s17846
Pubmed ID
Authors

Yi Chen, Liu, Faries

Abstract

THIS STUDY COMPARED ADHERENCE AND PERSISTENCE OF THREE BRANDED ANTIDEPRESSANTS: the serotonin and norepinephrine reuptake inhibitors (SNRIs) duloxetine and venlafaxine XR, and the selective serotonin reuptake inhibitor (SSRI) escitalopram; and generic selective SSRIs, and examined demographic and clinical predictors of adherence and persistence in patients with major depressive disorder in usual care settings.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 2%
Unknown 45 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 17%
Other 7 15%
Student > Bachelor 6 13%
Student > Postgraduate 6 13%
Student > Ph. D. Student 5 11%
Other 12 26%
Unknown 2 4%
Readers by discipline Count As %
Medicine and Dentistry 21 46%
Nursing and Health Professions 5 11%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Psychology 3 7%
Neuroscience 2 4%
Other 9 20%
Unknown 3 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2013.
All research outputs
#3,139,889
of 4,505,617 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#132
of 156 outputs
Outputs of similar age
#79,054
of 115,915 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#15
of 16 outputs
Altmetric has tracked 4,505,617 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 156 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 10th percentile – i.e., 10% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 115,915 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.